AlveoliX
Business Services · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Freiburgstrasse 3, Bern, Bern, 3010, Swi...Website
www.alveolix.comRevenue
<$5 MillionIndustry
About AlveoliX
Is AlveoliX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if AlveoliX is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when AlveoliX launches new products
Congratulate Masked Content for being promoted to Masked Content at AlveoliX
Click to see if AlveoliX had a recent Job posting/layoffs
Check if AlveoliX has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on AlveoliX recently announced quarterly report
AlveoliX, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once AlveoliX has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
AlveoliX is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AlveoliX is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AlveoliX.
AlveoliX Tech Stack
A closer look at the technologies used by AlveoliX
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AlveoliX
AlveoliX specializes in research and development of organs-on-chip technology aimed at enhancing drug discovery processes. Their innovative products, including the Barrier-on-Chip and Lung-on-Chip systems, recreate the complex micro-environments of human organs. The company targets clients in the pharmaceutical and biotechnology sectors, focusing o... Read More